Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-15-024984
Filing Date
2015-06-22
Accepted
2015-06-19 18:50:07
Documents
1
Effectiveness Date
2015-06-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7405
  Complete submission text file 0001140361-15-024984.txt   8448
Mailing Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139
Business Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139 650-463-4052
Cure Forward Corp. (Filer) CIK: 0001624526 (see all company filings)

EIN.: 461272619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-242208 | Film No.: 15943382